JAMES WELSH to Hodgkin Disease
This is a "connection" page, showing publications JAMES WELSH has written about Hodgkin Disease.
Connection Strength
0.030
-
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71.
Score: 0.030